VanEck Pharmaceutical ETF (PPH) closed at $111.11 (+0.73%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 47, RS Rating 78, -5.7% from its 52-week high, +7.1% year to date.
PPH·$111.11+0.73%
ResistanceSupportVol 14
63 bars
StockSetups
106108110112114116118R 117S 108
Vol MA14 219.79K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
VanEck Pharmaceutical ETF
Price111.11
Change+0.73%
Gap+0.98%
Rel volume—
Avg volume254.84K
Avg $ vol28.6M
SMA 20112.02
SMA 50111.95
SMA 200106.69
Price vs 50-0.76%
Price vs 200+4.14%
MA stackmixed
50/200 cross—
Supertrenddown · 115.46
RSI (14)47
MACD hist-0.15
MACD cross—
Stoch %K / %D34 / 28
ADX (14)11
+DI / −DI22 / 22
RSI divergence—
MACD divergence—
ATR %1.63%
ADR %1.17%
52w high117.87
52w low85.99
From 52w high-5.74%
Above 52w low+29.21%
New 52w highNo
SqueezeOff
Bollinger width6.86%
%B0.38
Donchian pos25.60%
Donchian high116.73
Donchian low109.17
AVWAP (52w high)112.65
vs AVWAP high-1.37%
AVWAP (52w low)102.43
vs AVWAP low+8.46%
OBV trendFlat
Chaikin MF (20)-0.35
Today vs 20d—
Avg vol (14d)219.79K
Avg vol (20d)254.84K
Avg $ vol (20d)28.6M
Market cap—
RS Rating78 / 99
RS 3m (vs SPY)-0.47%
RS 6m (vs SPY)-8.57%
RS line new highNo
Trend template5/8
Technical rank59.8
1 week-0.50%
1 month-5.74%
3 months+4.02%
6 months+8.25%
1 year+25.71%
YTD+7.12%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
Industry—
ExchangeXNAS
Shares out—
Employees—
ListedTue, Dec 20, 2011
Free float—
Float %—
Short interest2.49M
Days to cover9.2d
Short volume70.1%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank59.8 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance117.49
Support108.43
Days since event—
Candle confirm—
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.